Regulatory News
Thursday, December 8, 2016
BRIEF-Valeant announces phase 3 results for psoriasis treatment IDP-118
Dec 8 (Reuters) - Valeant Pharmaceuticals International Inc
:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment